Forskolin, a plant-derived compound, may offer a meaningful improvement in therapies for a highly aggressive leukemia known as KMT2A-rearranged Acute Myeloid Leukemia (KMT2A-r AML). Researchers at the University of Surrey report that this natural…
Continue Reading
News Source: www.sciencedaily.com
Leave a Reply